Thync Overview
- Founded
- 2010

- Status
- Private
- Employees
- 7

- Latest Deal Type
- Series A
- Latest Deal Amount
- $6M

- Investors
- 11
Thync General Information
Description
Developer of bioelectronic products designed to offer treatments for autoimmune disorders and mental health. The company's products target autonomic pathways important in a number of disease processes while providing safety and focusing on the commercialization of neurostimulation patches for consumer applications, enabling users to boost their energy level by directly activating nerves and neurons.
Contact Information
- 140 West Main Street
- Los Gatos, CA 95030
- United States
Thync Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Later Stage VC (Series A) | 16-Feb-2018 | $6M | 000.00 | Completed | Generating Revenue | |
7. Equity Crowdfunding | 000.00 | Completed | Generating Revenue | |||
6. Early Stage VC (Series B2) | 23-Jan-2015 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
5. Early Stage VC (Series B1) | 08-Oct-2014 | 00.00 | 0000 | 000.00 | Completed | Generating Revenue |
4. Early Stage VC (Series B) | 01-Mar-2013 | 000 | 00.00 | 0000 | Completed | Generating Revenue |
3. Grant | 01-Jan-2012 | 00.000 | 00.00 | Completed | Generating Revenue | |
2. Early Stage VC (Series A) | 01-Sep-2011 | $2.3M | $2.3M | 000 | Completed | Generating Revenue |
1. Accelerator/Incubator | Completed | Startup |
Thync Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B2 | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00.00 | 00.00 | |
Series B1 | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series B | 1,328,125 | $0.000100 | 8% | $1.6 | $1.6 | 1x | $1.6 | 9.44% |
Series A | 2,875,000 | $0.000100 | 8% | $0.8 | $0.8 | 1x | $0.8 | 20.44% |
Thync Patents
Thync Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3784337-A1 | Streamlined and pre-set neuromodulators | Pending | 24-Apr-2018 | 00000000000 | |
US-20190321636-A1 | Streamlined and pre-set neuromodulators | Pending | 24-Apr-2018 | 00000000000 | 0 |
US-20200297999-A1 | Systems and methods for applying electrical energy to treat psoriasis | Pending | 22-May-2017 | 000000000 | |
US-20180333574-A1 | Systems and methods for applying electrical energy to treat psoriasis | Abandoned | 22-May-2017 | 000000000 | |
US-9956405-B2 | Transdermal electrical stimulation at the neck to induce neuromodulation | Active | 07-Dec-2016 | A61N1/36025 | 00 |
Thync Executive Team (9)
Thync Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
Samir Kaul | Khosla Ventures | Board Member | 000 0000 |
Thync Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialThync Investors (11)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Noosphere Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
Ariel Poler | Angel (individual) | Minority | 000 0000 | 000000 0 | |
Sugam Arora | Angel (individual) | Minority | 000 0000 | 000000 0 | |
United States Department of Defense | Government | 000 0000 | 000000 0 | ||
U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 |